PD 169316
CAS No. 152121-53-4
PD 169316( PD169316 | PD-169316 )
Catalog No. M12125 CAS No. 152121-53-4
A potent, selective p38 MAPK inhibitor with IC50 of 89 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 43 | In Stock |
|
| 10MG | 71 | In Stock |
|
| 25MG | 125 | In Stock |
|
| 50MG | 203 | In Stock |
|
| 100MG | 357 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePD 169316
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective p38 MAPK inhibitor with IC50 of 89 nM.
-
DescriptionA potent, selective p38 MAPK inhibitor with IC50 of 89 nM; displays >100-fold selectivity over ERK, PKA, PKCα; prevent p38 phosphorylation while promotes the phosphorylation of the pro-survival SAPK/JNK and ERK.
-
In VitroPD169316 (10 μM) inhibits TGFβ and Activin A, but not BMP4 signaling in CaOV3 cells. PD169316 (0.2-20 μM) inhibits TGFβ-induced Smad2 nuclear translocation, Smad7 mRNA induction, and reporter gene activity in CaOV3 cells. PD169316 (10 μM) shows a significantly increased rate of proliferation in Nestin knockdown cells, and can rescue the effect of Nestin knockdown on cell viability in the absence of EGF. PD169316 significantly inhibits p38 MAP kinase activity with no significant change in ERK activity in PC12 cells. PD169316 (10 μM) blocks apoptosis induced by trophic factor withdrawal in differentiated PC12 cells.PD169316 (10 μM, 30 min) selectively inhibits the kinase activity of the phosphorylated p38 without hindering upstream kinases to phosphorylate p38. Increased phospho p-38 levels in the presence of PD169316 are most likely due to blockade of negative feedback loop of dephosphorylation of p38 MAPK by MAPK phosphatases. Western Blot Analysis Cell Line:Ishikawa PRB or PRA cells.Concentration:10 μM.Incubation Time:30 min.Result:Did not inhibit MEKK1-induced p38 phosphorylation.
-
In VivoPD169316 (1 mg/kg, intramuscular injection every day for 14 consecutive days) shows antiviral activity in a suckling mouse model. Animal Model:EV71-challenged suckling mouse model (7-day-old Kunming mice).Dosage:1 mg/kg. Administration:Intramuscular injection every day for 14 consecutive days.Result:Showed antiviral activity.
-
SynonymsPD169316 | PD-169316
-
PathwayMAPK/ERK Signaling
-
Targetp38 MAPK
-
Recptorp38
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number152121-53-4
-
Formula Weight360.3412
-
Molecular FormulaC20H13FN4O2
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESO=[N+](C1=CC=C(C2=NC(C3=CC=NC=C3)=C(C4=CC=C(F)C=C4)N2)C=C1)[O-]
-
Chemical NamePyridine, 4-[4-(4-fluorophenyl)-2-(4-nitrophenyl)-1H-imidazol-5-yl]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Gallagher TF, et al. Bioorg Med Chem. 1997 Jan;5(1):49-64.
2. Krishnamoorthy M, et al. J Biochem. 2009 Feb;145(2):177-84.
3. Kozawa O, et al. Cell Signal. 2000 Jul;12(7):447-50.
molnova catalog
related products
-
EO-1606
EO-1606 is a p38MAP kinase inhibitor with anti-inflammatory activity and may be used in studies of Alzheimer;s disease and dermatitis.
-
Nek2-IN-5
Nek2-IN-5 (NCL00017509) is a potent and selective inhibitor of NIMA-related kinase 2 (Nek2).
-
UR13870
UR-13870 (Org 48762-0) is an orally active and selective inhibitor of p38 mitogen-activated protein kinase (MAPK), which prevents bone damage in collagen-induced arthritis in mice.
Cart
sales@molnova.com